Stage 1 — Conjugate Them

ADC Conjugation Services

You provide the antibody and linker-payload — we handle the conjugation chemistry and deliver a characterized, ready-to-use conjugate. We support every major conjugation chemistry and format with integrated access to trusted partners for antibody, linker, and payload synthesis.

← Back to Stage 1 Overview

Conjugate Types We Produce

We work with a wide range of antibody formats and payload classes. You supply the components; we perform the conjugation and deliver the finished conjugate.

Antibody-Drug Conjugates (ADC)

  • IgG1, IgG2, IgG4 formats
  • Bispecific antibodies (BsAb)
  • Dual-payload ADCs
  • Single-chain variable fragment (scFv) conjugates
  • Isotype control ADC generation

Next-Generation Conjugate Formats

  • Degrader-Antibody Conjugates (DAC) — PROTAC/molecular glue payloads
  • Antibody-Oligonucleotide Conjugates (AOC) — siRNA, ASO, mRNA
  • Custom bioconjugate formats on request
  • Multifunctional conjugation platforms

Research & Tool Conjugates

  • Antibody–fluorophore conjugates (flow cytometry, imaging)
  • Enzyme conjugates (HRP, AP)
  • Biotinylated antibodies
  • Custom labeling for assay development

Conjugation Chemistry Options

We offer both traditional stochastic and precision site-specific conjugation strategies, selected based on your DAR requirements, payload chemistry, and development stage.

Stochastic Conjugation

  • Native cysteine (interchain disulfide reduction)
  • Native lysine (NHS ester chemistry)
  • Broad DAR distribution (DAR 2–8)
  • Cost-effective for early-stage screening
  • Rapid turnaround for POC studies

Site-Specific Conjugation

  • Engineered cysteine (THIOMAB) — homogeneous DAR 2
  • Glycan conjugation (oxidized sugar attachment)
  • ‘Click’ chemistry (DBCO/azide, TCO/tetrazine)
  • Unnatural amino acid incorporation
  • Improved PK/PD and therapeutic index vs. stochastic

Linker-Payload Optimization

Not sure which of your linker-payload options is best suited to your target? Our team can help you design a screening panel and use our HTP platform to conjugate and test multiple combinations in parallel — dramatically reducing the time to identify your lead ADC. You provide the antibody and the linker-payload candidates; we run the conjugations and characterization.

Learn About HTP Screening →

What We Need From You

You Provide

  • Your antibody (we can advise on format and quantity needed)
  • Your linker-payload (client-supplied; synthesis available through trusted partners)
  • Your target DAR and scale requirements

We Deliver

  • Purified, characterized conjugate at your requested scale
  • DAR, purity, and yield data
  • Full data report and recommendations for next steps

Ready to Make Your Conjugate?

Request a quote and our scientists will reach out to discuss your project within 1 business day.

Request a Quote